Display options
Cite
Gee SH, Taylor DM, Shergill SS, et al. Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit. Ther Adv Psychopharmacol. 2016;7(2):79-83doi: 10.1177/2045125316677027.
Gee, S. H., Taylor, D. M., Shergill, S. S., Flanagan, R., & MacCabe, J. H. (2017). Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit. Therapeutic advances in psychopharmacology, 7(2), 79-83. https://doi.org/10.1177/2045125316677027
Gee, Siobhan H, et al. "Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit." Therapeutic advances in psychopharmacology vol. 7,2 (2017): 79-83. doi: https://doi.org/10.1177/2045125316677027
Gee SH, Taylor DM, Shergill SS, Flanagan R, MacCabe JH. Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit. Ther Adv Psychopharmacol. 2017 Feb;7(2):79-83. doi: 10.1177/2045125316677027. Epub 2016 Dec 02. PMID: 28255437; PMCID: PMC5315231.
Copy Download .nbib Format: NLM
Share it on

Ther Adv Psychopharmacol. 2017 Feb;7(2):79-83. doi: 10.1177/2045125316677027. Epub 2016 Dec 02.

Effects of a smoking ban on clozapine plasma concentrations in a nonsecure psychiatric unit.

Therapeutic advances in psychopharmacology

Siobhan H Gee, David M Taylor, Sukhwinder S Shergill, Robert Flanagan, James H MacCabe

Affiliations

  1. Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, UK.
  2. Institute of Pharmaceutical Science, King's College London, 16 De Crespigny Park, Camberwell, London SE5 8AF, UK.
  3. Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  4. Toxicology Unit, Clinical Biochemistry, King's College Hospital NHS Foundation Trust, London, UK.

PMID: 28255437 PMCID: PMC5315231 DOI: 10.1177/2045125316677027

Abstract

BACKGROUND: Tobacco smoke is known to affect plasma levels of some drugs, including the antipsychotic clozapine. The effects of suddenly stopping smoking on patients who take clozapine can be severe, as plasma concentrations are expected to rapidly rise, potentially leading to toxicity. A ban on smoking at South London and the Maudsley NHS Foundation Trust (SLaM) was implemented in 2014, and this was expected to affect the plasma concentrations of clozapine for inpatients at the time. This study aimed to determine whether plasma concentrations of clozapine were affected, and additionally, in line with observations from other authors, whether levels of reported violence would also be affected.

METHODS: The smoking habits of all patients at SLaM who smoked and were prescribed clozapine were recorded both before and after the ban. The Glasgow Antipsychotic Side Effect Scale for Clozapine (GASS-C) scale was used to evaluate side-effect burden. Clozapine doses and plasma concentrations were also collected.

RESULTS: In total, 31 patients were included in this study. The mean clozapine dose before the ban was 502 mg/day, and this did not change significantly after the ban. Similarly, there were no significant changes in clozapine or norclozapine plasma concentrations, or in GASS-C scores. There was no change in the amount of tobacco patients reported smoking before or after the ban. A modest but statistically significant reduction in violent incidences was observed.

CONCLUSIONS: Our data suggest that a ban on smoking for patients taking clozapine on open wards at inpatient hospital sites had little impact on clozapine plasma concentrations, because patients continued to smoke tobacco if allowed to leave. Smoking bans may result in a reduction in violent incidences.

Keywords: antipsychotic agents; clozapine; smoking; violence

Conflict of interest statement

Conflict of interest statement: Ms Gee has received consultancy fees from Sunovion, and lecturing honoraria from Sunovion, Otsuka and Janssen. Professor Taylor has received research funding from Janss

References

  1. Acta Psychiatr Scand. 2010 May;121(5):393-7 - PubMed
  2. Aust N Z J Psychiatry. 2005 Oct;39(10):866-85 - PubMed
  3. Hosp Community Psychiatry. 1991 Jun;42(6):636-7 - PubMed
  4. Hosp Community Psychiatry. 1991 Apr;42(4):408-12 - PubMed
  5. J Clin Psychopharmacol. 2004 Feb;24(1):70-8 - PubMed
  6. J Clin Psychopharmacol. 2001 Dec;21(6):569-74 - PubMed
  7. Behav Sci Law. 2002;20(5):507-22 - PubMed
  8. Gen Hosp Psychiatry. 1994 May;16(3):200-4 - PubMed

Publication Types